| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, CLO &Secretary
2 companies
Franchini Indrani Lall is a Director at AVNS with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, CLO &Secretary | Sale+OE | 329 | $155.30 | $51,094.50 | -1.5% | -3.3% | +52.7% | |
| Feb 2, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, CLO &Secretary | Sale+OE | 1,591 | $170.99 | $272,050.04 | -11.6% | -13.1% | +56.8% | |
| Apr 6, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, CLO &Secretary | Sell | 3,500 | $210.00 | $735,000.00 | -100% | -8.7% | -27.2% | |
| Feb 2, 2023 | ALNY Alnylam Pharmaceuticals, Inc. | EVP, CLO &Secretary | Sale+OE | 1,675 | $226.01 | $378,562.51 | -9.4% | -13.2% | -24.7% |